HTGF | High-Tech Gruenderfonds
High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Technology
AICA SA
Seed Round in 2025
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
Alpine Eagle
Seed Round in 2025
Alpine Eagle is a technology company specializing in counter-unmanned aerial systems (C-UAS). It develops hardware and software solutions to detect and mitigate threats posed by low-cost, autonomous drones. The company's offerings help identify the probability of drone incursions, enabling clients to enhance their security measures.
Variolytics
Venture Round in 2025
Variolytics is a developer of advanced measurement technologies, specializing in mass spectrometry for environmental applications, particularly in sewage treatment plants. The company focuses on measuring all gas components, including greenhouse gases, within aeration tanks. Variolytics offers a range of products including measuring devices, sensor technologies, and monitoring systems that facilitate accurate data collection and process integration. In addition to its innovative measurement solutions, the company conducts process engineering research and development, providing expert advice and implementation services to help businesses optimize their industrial processes. By delivering insights into process dynamics, Variolytics enables companies to make informed decisions and enhance operational efficiency.
Laclarée
Seed Round in 2025
Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.
alteva
Pre Seed Round in 2025
Alteva is a technology company specializing in the development of advanced battery cells. Its primary focus is on creating high-energy density, safety-conscious batteries tailored for the decarbonization of hard-to-electrify transport sectors such as aviation and heavy-duty vehicles. The company's innovative approach involves the use of ultralight carbon materials and sustainable raw materials, aiming to enhance battery performance, longevity, and compatibility with existing production facilities.
Lindis Blood Care
Venture Round in 2024
Lindis Blood Care is focused on improving the outcomes of cancer surgeries through the development of an innovative medical device that removes cancer cells from salvaged blood. This technology facilitates the possibility of self-blood administration, allowing cancer patients to receive autologous blood transfusions during their procedures. By enabling the safe use of blood collected during surgery, Lindis Blood Care aims to enhance the recovery process and overall well-being of patients undergoing cancer treatment.
Doctorflix
Seed Round in 2024
Doctorflix is a medical education platform designed for healthcare professionals seeking to enhance their knowledge and skills in treatment methods. The platform focuses on simplifying and democratizing the exchange of medical knowledge by connecting doctors, hospitals, and pharmaceutical companies. It offers a diverse array of content, including on-demand videos, live events, articles, and podcasts, facilitating the transformation of theoretical knowledge into practical applications. With a commitment to advancing professional development, Doctorflix aims to accelerate the continuing education of medical professionals worldwide, leveraging its expertise in both the medical and technological sectors to deliver effective training solutions.
IonKraft
Seed Round in 2024
IonKraft, a German technology company, specializes in plasma coating for multi-material plastic containers. Their innovative plasma-enhanced chemical vapor deposition process enables recyclability of complex packaging, serving industries such as food, pharmaceuticals, cosmetics, and chemicals. By promoting material reduction and reuse, IonKraft aims to enhance performance while lowering costs, with support from the German Federal Ministry for Economic Affairs and Energy.
Nuuron
Seed Round in 2024
Nuuron is a neurotechnology company specializing in the development of a non-invasive, photonic neurostimulation device called the Memory-Pacemaker. This device is designed to help Alzheimer's patients store and retrieve memories by activating the memory center in the brain via the retina, acting as a computer-brain interface. The company's proprietary platform algorithms generate ultra-high frequency, digital photonic stimuli to achieve this.
Autarkize
Seed Round in 2024
Autarkize is a developer of a patented pyrolysis system technology that focuses on achieving energy and fertilizer self-sufficiency through the carbonization of residual biomasses. The company offers a market-ready system that extracts high-quality gas composed of methane and hydrogen from various biomass residues in a decentralized manner. Its technology is capable of processing all types and amounts of biomass, resulting in significantly higher energy density compared to traditional carbonization systems. Additionally, the process generates biochar, which enhances soil quality and contributes to the reduction of greenhouse gas emissions. By enabling industrial companies to promote energy cleaning and decarbonization, Autarkize plays a vital role in advancing sustainable energy solutions.
Lymphatica Medtech
Series B in 2024
Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.
Symphera
Seed Round in 2024
Symphera is a developer of an innovative surgical system focused on enhancing the efficiency of minimally invasive procedures. The company specializes in a laparoscopic surgical tool that aims to radically simplify and expedite surgical processes. By prioritizing control, autonomy, safety, and efficiency, Symphera enables healthcare providers to perform surgeries with greater precision and effectiveness. Through its all-in-one surgical system, the company is committed to transforming the landscape of surgical practices, making advanced medical techniques more accessible and streamlined for both practitioners and patients.
ABH Optics
Pre Seed Round in 2024
ABH Optics specializes in manufacturing high-quality, ultra-thin and lightweight eyeglass lenses. Their innovative lenses, designed for high myopia patients, offer enhanced comfort and aesthetic appeal without compromising vision correction. This is achieved through a proprietary material that enables significant reduction in lens thickness and weight compared to traditional lenses.
DeepSkill
Seed Round in 2024
DeepSkill is a technology-driven agency and platform focused on enhancing employee development through personalized coaching programs. By utilizing a modular coaching system and intelligent algorithms, DeepSkill offers tailored learning experiences that combine e-learning with digital coaching. The platform provides a variety of digital coaching, workshops, and educational programs aimed at facilitating digital transformation. This approach allows participants to engage in individualized learning journeys that align with their personal goals and preferences, thereby empowering employees to benefit from customized coaching for the first time.
Synthara
Venture Round in 2024
Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.
Seqana
Seed Round in 2024
Seqana is a developer of satellite-based software that focuses on monitoring soil organic carbon (SOC) to support nature-based climate services. The company provides an innovative, cost-effective solution for project developers, agribusinesses, NGOs, and large corporations, allowing them to obtain actionable insights into soil health and carbon sequestration practices. By leveraging remote sensing technology, Seqana enables clients to measure and understand soil carbon levels quickly and accurately, contributing to efforts in combating climate change at a global scale. Through its cutting-edge monitoring platform, Seqana supports the transition to sustainable agricultural practices and enhances the value of environmental initiatives.
Cultimate Foods
Seed Round in 2024
Cultimate Foods is a cellular agriculture company focused on cultivated fat for hybrid alternative-meat products. It develops cell-cultured fat that mimics the structure of animal fat tissue, using a three-dimensional cultivation approach to create structured fat ingredients and lower production costs. The company also pursues cell-engineered adipose tissue to enable meat alternatives that combine cultivated fat biomass with other ingredients, delivering the flavor and texture of meat while supporting sustainability.
Proxima Fusion
Seed Round in 2024
Proxima Fusion develops innovative fusion power plants using optimized stellarators. These magnetic confinement devices aim to generate emissions-free power through nuclear fusion, providing a clean and safe energy source.
Graswald.ai
Seed Round in 2024
Graswald.ai specializes in the development of natural and digital 3D environments tailored for the entertainment industry. The company focuses on creating photorealistic 3D vegetation models and nature assets that enhance visual storytelling in various applications, including visual effects, gaming, and concept art. By offering a diverse range of models, Graswald enables content creators to construct immersive ecosystems within their digital productions, thereby increasing realism and depth in animated content. The platform's emphasis on natural elements serves to elevate the quality and authenticity of virtual worlds, making it a valuable resource for professionals in the creative sectors.
CustomSurg
Seed Round in 2024
CustomSurg is a company focused on enhancing the treatment of complex bone fractures, particularly those involving joints. It develops fracture-specific bone plates that are tailored to match the unique anatomy of individual patients using advanced technologies such as computer tomography and 3D printing. This personalized approach provides improved stability for bone repairs, which can significantly reduce surgery time and lower long-term healthcare costs for patients. By offering a software solution for optimized surgical planning and designing patient-specific implants and instruments, CustomSurg shifts the treatment strategy from a subjective to an objective framework, aiming to improve outcomes for approximately 400,000 trauma patients in a market valued at $1.2 billion. The involvement of a Harvard Medical School surgeon in directing the medical aspects of the company adds a layer of credibility to its innovative offerings.
Tubulis
Series B in 2024
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
Cyclize
Seed Round in 2024
Cyclize is a technology company focused on decarbonizing the chemical industry. It develops a proprietary process that converts mixed plastic waste and CO2 into syngas, a versatile intermediate used to produce various chemicals and fuels. This process aims to replace fossil feedstock, such as natural gas, reducing reliance on non-renewable resources and minimizing greenhouse gas emissions.
Rabot Energy
Series A in 2024
Rabot Energy is a progressive green electricity supplier offering flexible and intelligent tariffs for residential customers and electric vehicles. Its platform utilizes real-time market data to optimize charging schedules, helping users save money, reduce their carbon footprint, and simplify vehicle ownership.
BTRY
Pre Seed Round in 2024
BTRY, spun off from EMPA and ETH, specializes in developing the first energy-dense solid-state battery, leveraging advanced semiconductor manufacturing techniques. The company aims to provide a sustainable energy storage solution, offering customizable battery properties to meet diverse customer needs, thereby reducing energy consumption and waste from solvent evaporation and recycling.
Midel Photonics
Seed Round in 2023
Midel Photonics specializes in the manufacture of laser beam shapers and splitters utilizing diffractive optics to efficiently redistribute laser light. The company's products are designed to enhance process quality and reduce defects across a variety of applications, ensuring compatibility with leading laser types. By providing innovative solutions in laser beam shaping, Midel Photonics aims to accelerate processes for businesses, contributing to improved operational efficiency and effectiveness.
RAYDIAX
Seed Round in 2023
RAYDIAX is a manufacturer of advanced therapy-assist computed tomography (CT) systems aimed at enhancing the quality of minimally invasive medical interventions, particularly for tumor treatments. The company develops imaging solutions that integrate a navigation system with both 2D and 3D X-ray live imaging, enabling healthcare providers to perform procedures with greater safety and efficiency. RAYDIAX's technology is designed to reduce the risk of postoperative complications, ultimately resulting in shorter hospital stays and quicker recovery times for patients. Through its innovative approach, RAYDIAX seeks to improve outcomes for both patients and clinicians in the realm of cancer therapy.
Inovedis
Series A in 2023
Inovedis specializes in innovative medical technologies aimed at optimizing patient care while reducing time and costs within the healthcare sector. The company develops advanced surgical devices, such as its flagship product designed for treating shoulder injuries, which leverages science-based technology to enable anatomical reconstruction of physiological tendon-bone connections.
Delft Circuits
Series A in 2023
Delft Circuits manufactures specialized hardware for quantum engineers and industries. They offer in-house cleanroom fabrication, cryogenic high-frequency laboratories, and expertise in microwave design, engineering, and superconducting materials to enable customers to achieve scalable, high-performance Input/Output (I/O) solutions.
BEEoled
Series A in 2023
BEEoled is a technology company specializing in the development of advanced organic light-emitting diode (OLED) technology. Their innovative approach centers on the creation of a blue elementary emitter designed around a single atom, which allows for the production of a full spectrum of colors by mixing three primary colors. This technology offers significant enhancements in efficiency, brightness, and operational stability, while also reducing costs through a simplified device structure. BEEoled's advancements enable manufacturers to create high-quality OLED displays for a variety of applications, including smartphones, screens, and televisions.
Yond
Pre Seed Round in 2023
Yond is a technology company that specializes in operating a Gym Operating System. This system is designed to automate and streamline various aspects of gym operations, enhancing the overall scalability and efficiency of fitness enterprises. The company's offerings include a comprehensive suite for member management, automated billing, and intelligent access control, enabling gyms to improve customer experiences and optimize their processes.
Supportwave
Seed Round in 2023
Supportwave is an IT support platform that connects businesses with a global network of vetted IT engineers for on-demand assistance. It offers enterprise SaaS to manage all IT needs in one place, enabling companies to build and scale remote IT teams swiftly. Supportwave provides on-site support across the US and UK, and global remote support within 30 seconds.
PlastFormance
Venture Round in 2023
PlastFormance is a manufacturer specializing in high-performance plastic compounds. It develops innovative chemical processes to enhance the properties of these compounds, notably increasing their filler content while retaining injection-molding capabilities. The company's portfolio includes thermally conductive, electrically conductive, and radiation-shielding plastics, catering to diverse industries requiring effective thermal management, power generation, or radiation protection. These compounds are designed to excel in applications demanding heat dissipation and radiation shielding, supporting large-scale production.
AIM3D
Venture Round in 2023
AIM3D GmbH, founded in 2017 and based in Rostock, Germany, specializes in the design and manufacture of advanced 3D printers for metal and plastic applications. Originating as a spin-off from the University of Rostock, the company addresses the high material costs that often hinder the industrial adoption of additive manufacturing techniques, particularly for metal parts. AIM3D aims to revolutionize the additive manufacturing market by offering a printer that allows for the use of multiple types of materials, including metals, ceramics, and plastics, within a single machine. This innovative approach enhances cost-efficiency and enables businesses in the additive manufacturing sector to increase productivity while reducing operational costs.
Doctorflix
Seed Round in 2023
Doctorflix is a medical education platform designed for healthcare professionals seeking to enhance their knowledge and skills in treatment methods. The platform focuses on simplifying and democratizing the exchange of medical knowledge by connecting doctors, hospitals, and pharmaceutical companies. It offers a diverse array of content, including on-demand videos, live events, articles, and podcasts, facilitating the transformation of theoretical knowledge into practical applications. With a commitment to advancing professional development, Doctorflix aims to accelerate the continuing education of medical professionals worldwide, leveraging its expertise in both the medical and technological sectors to deliver effective training solutions.
Proxima Fusion
Pre Seed Round in 2023
Proxima Fusion develops innovative fusion power plants using optimized stellarators. These magnetic confinement devices aim to generate emissions-free power through nuclear fusion, providing a clean and safe energy source.
Rabot Energy
Seed Round in 2023
Rabot Energy is a progressive green electricity supplier offering flexible and intelligent tariffs for residential customers and electric vehicles. Its platform utilizes real-time market data to optimize charging schedules, helping users save money, reduce their carbon footprint, and simplify vehicle ownership.
Mosanna Therapeutics
Seed Round in 2023
Mosanna Therapeutics is a biotechnology company based in Basel that focuses on improving patient outcomes and quality of life for individuals with high unmet medical needs. The company employs a precision medicine approach, specializing in the development of medicinal nasal sprays. Mosanna carefully selects innovative medicines for further development and collaborates with leading contract research organizations to ensure expertise in specialized fields. This strategy enables hospitals and doctors to effectively treat patients suffering from various diseases.
Phytonics
Seed Round in 2023
Phytonics specializes in designing and providing anti-reflective coating products for photovoltaic modules. These coatings offer superior light-trapping capabilities, enhancing solar energy absorption and facilitating the transition to renewable energy sources.
AICA SA
Seed Round in 2023
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
Refined Laser Systems
Seed Round in 2023
Refined Laser Systems is a specialized manufacturer of biophotonics devices, focusing on stain-free tissue diagnostics using its proprietary fiber-based tunable picosecond laser technology. The company's innovative laser systems enable rapid and reliable diagnoses, significantly reducing the time required compared to traditional methods.
PraxisEins.
Pre Seed Round in 2023
PraxisEins is a healthcare startup focused on enhancing outpatient care through innovative technology. The company develops a software-enabled platform that assists physicians in digitizing their processes, ultimately aimed at improving patient care and alleviating administrative burdens. By leveraging modern technology, PraxisEins enables doctors to conduct same-day consultations with patients, addressing the supply vacuum in outpatient services. Through its solutions, the company seeks to streamline workflows for healthcare providers and enhance the overall efficiency of outpatient care.
Variolytics
Seed Round in 2022
Variolytics is a developer of advanced measurement technologies, specializing in mass spectrometry for environmental applications, particularly in sewage treatment plants. The company focuses on measuring all gas components, including greenhouse gases, within aeration tanks. Variolytics offers a range of products including measuring devices, sensor technologies, and monitoring systems that facilitate accurate data collection and process integration. In addition to its innovative measurement solutions, the company conducts process engineering research and development, providing expert advice and implementation services to help businesses optimize their industrial processes. By delivering insights into process dynamics, Variolytics enables companies to make informed decisions and enhance operational efficiency.
Crocus Labs
Seed Round in 2022
Crocus Labs is a Berlin-based deep tech company specializing in advanced light engine technology. It develops energy-saving solutions for wellness, horticultural, and specialty lighting applications, aiming to bring its innovations to residential, commercial, and industrial spaces worldwide.
InCirT
Seed Round in 2022
InCirT develops ultra-high-speed, low-power data converters and IP solutions that enhance wireless communication and radar performance. The company focuses on modulation bandwidth and energy efficiency, delivering wide-bandwidth technology suitable for integration into wireless chipsets and digital radar devices. Its solutions support mmWave 5G and 6G applications, enabling more energy-efficient and compact system designs.
DeepScenario
Pre Seed Round in 2022
DeepScenario is a developer of an advanced AI scenario engine that serves as an end-to-end platform for the testing and validation of autonomous systems. The company specializes in real-time road traffic data, facilitating the development of intelligent driving solutions by leveraging intelligent analysis of aerial image data. Its platform enables the creation of various traffic scenarios, which aids companies in developing, testing, and validating their automated driving technologies. DeepScenario addresses customer inquiries through multiple channels, including phone, email, and online applications, ensuring effective communication and support for its clients.
Resolve BioSciences
Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's innovative technology enables researchers to obtain high-resolution spatial views of subcellular gene expression activities. Resolve BioSciences offers a range of services that encompass bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among others. Their expertise extends to various fields, including neuroscience, oncology, infectious diseases, and agrigenomics, facilitating advanced studies in cell atlasing and single-cell analysis.
Awake Mobility
Seed Round in 2022
Awake Mobility develops a predictive maintenance platform that supports public and private bus operators with digital transformation. The platform uses IoT and machine learning to monitor city buses in real-time, preventing breakdowns and failures, and providing operators with data on their fleet's health.
FaCellitate
Seed Round in 2022
FaCellitate is a developer of innovative biomedical technology focused on enhancing cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The company specializes in creating polymeric platforms that provide chemically defined, animal- and xeno-free cell culture coatings. These advanced coatings facilitate improved cellular interactions, thereby significantly enhancing cell culture practices in biological research. By offering smart lab surfaces, FaCellitate enables researchers to conduct more effective experiments, contributing to advancements in various fields of biomedical research.
GlassDollar
Seed Round in 2022
GlassDollar is a technology company that digitizes and scales corporate-startup collaboration. It assists corporations in identifying, implementing, and scaling startup solutions for tangible results. The platform streamlines innovation activities by leveraging data and automation.
EcoPals
Seed Round in 2022
EcoPals is a company focused on developing sustainable solutions for road construction by transforming waste plastics into innovative materials. It specializes in creating a carbon-reducing asphalt additive derived from non-recyclable plastics, providing a low-cost alternative to traditional bitumen additives. This approach not only helps address global plastic waste issues but also enhances the quality of road infrastructure. By offering eco-friendly and cost-effective alternatives, EcoPals aims to contribute to a more sustainable future in the construction industry.
DeepSkill
Pre Seed Round in 2022
DeepSkill is a technology-driven agency and platform focused on enhancing employee development through personalized coaching programs. By utilizing a modular coaching system and intelligent algorithms, DeepSkill offers tailored learning experiences that combine e-learning with digital coaching. The platform provides a variety of digital coaching, workshops, and educational programs aimed at facilitating digital transformation. This approach allows participants to engage in individualized learning journeys that align with their personal goals and preferences, thereby empowering employees to benefit from customized coaching for the first time.
Noscendo
Venture Round in 2022
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, focused on the development of bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Utilizing Next Generation Sequencing technology, Noscendo's platform offers a hypothesis-free approach to detect a wide range of infection-causing microbes, including bacteria, fungi, DNA viruses, and parasites, from a single standard blood draw. This innovative method eliminates the need for prior cultivation or specific knowledge about the infection's nature, empowering intensive care clinicians to make accurate distinctions between commensals, contamination, and genuine infections. Through its proprietary algorithms, Noscendo enhances the identification process, ultimately aiming to improve patient outcomes in critical care settings.
Graswald.ai
Seed Round in 2022
Graswald.ai specializes in the development of natural and digital 3D environments tailored for the entertainment industry. The company focuses on creating photorealistic 3D vegetation models and nature assets that enhance visual storytelling in various applications, including visual effects, gaming, and concept art. By offering a diverse range of models, Graswald enables content creators to construct immersive ecosystems within their digital productions, thereby increasing realism and depth in animated content. The platform's emphasis on natural elements serves to elevate the quality and authenticity of virtual worlds, making it a valuable resource for professionals in the creative sectors.
Tubulis
Series B in 2022
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
Venly
Series A in 2022
Venly is a Web3 platform that enables developers to integrate any blockchain into their projects. It focuses on simplifying blockchain technology, facilitating transactions between individuals, ecosystems, and decentralized applications.
Ebenbuild
Seed Round in 2022
Ebenbuild is a technology company that specializes in developing and commercializing advanced health tech solutions focused on respiratory diseases. Building on two decades of research from TU Munich, the company employs lung simulation models to create a versatile platform with applications in both drug development and healthcare. One of its key innovations is a digital trials application that enhances drug delivery predictions, thereby accelerating the drug development process for Biotech, Pharma, and MedTech companies. This application allows for the optimization of delivery parameters before clinical trials, thus increasing success rates. Additionally, Ebenbuild's healthcare application integrates with hospital IT systems to provide actionable intelligence at the patient's bedside. It focuses on personalizing mechanical ventilation for patients with Acute Respiratory Distress Syndrome, significantly improving their prognosis. By continuously expanding its platform to address various indications, Ebenbuild aims to enhance patient outcomes while supporting medical staff and healthcare systems.
Valispace
Seed Round in 2022
Valispace GmbH, founded in 2015 and based in Bremen, Germany, develops a browser-based engineering software platform designed to enhance productivity in the development of complex hardware products such as satellites and rockets. The platform serves as a comprehensive Engineering Information Management System, facilitating team collaboration across various aspects of the engineering lifecycle, including requirements management, data-driven functional design, and detailed systems design. By providing tools for automated verification and live documentation, Valispace allows companies to transition from traditional waterfall methods to more agile hardware development approaches. Its software enables full traceability and offers a centralized location for managing test procedures and engineering data, ultimately helping clients reduce development time, improve quality, and lower costs across their projects.
Senodis
Seed Round in 2022
Senodis is a company focused on advancing the digital transformation of the industrial sector, particularly in the metal industry. It specializes in developing innovative industrial automation technology that continuously identifies hot-formed metal components. By leveraging its expertise in materials research, optical sensors, and digital data analysis, Senodis addresses the challenges of digitization, providing essential solutions and applications that enhance production processes. The company aims to create transparency for its clients, enabling them to reduce costs effectively and improve operational efficiency through tailored technological advancements.
Lindis Blood Care
Venture Round in 2022
Lindis Blood Care is focused on improving the outcomes of cancer surgeries through the development of an innovative medical device that removes cancer cells from salvaged blood. This technology facilitates the possibility of self-blood administration, allowing cancer patients to receive autologous blood transfusions during their procedures. By enabling the safe use of blood collected during surgery, Lindis Blood Care aims to enhance the recovery process and overall well-being of patients undergoing cancer treatment.
Aegiq
Seed Round in 2022
Aegiq Ltd. is a company specializing in the development of semiconductor-based quantum photonic chips, which are designed for various communications and computing applications such as broadband quantum communication, imaging, microscopy, and scalable quantum computing. Founded in 2019 and headquartered in Sheffield, United Kingdom, Aegiq adopts a full-stack photonic quantum computing approach that provides speed, compactness, and modularity. The company's technology serves a diverse range of industries, including defense, aerospace, cybersecurity, and artificial intelligence, addressing complex computational challenges. Aegiq's integrated photonic platform aims to facilitate large-scale quantum computing with multi-million qubit operations, offering a comprehensive portfolio of products and systems related to quantum cybersecurity and networking.
MetisMotion
Seed Round in 2022
MetisMotion GmbH, founded in 2018 and headquartered in Munich, Germany, specializes in the development of advanced actuators designed for various industrial applications, including robotics, aviation, and automotive sectors. The company focuses on creating lightweight, high force-density actuators that enhance performance through significant reductions in weight and space. MetisMotion's technology integrates the advantages of solid-state actuators with traditional drive systems, facilitating the electrification of hydraulic systems to achieve greater force output and extended displacement capabilities. This innovative approach positions MetisMotion as a key player in driving efficiency and modernization within the actuator market.
Ceregate
Series A in 2022
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company focuses on developing a computer-brain interface (CBI) technology that enhances the programming of neuromodulation systems. This innovative platform allows for the direct transmission of information into human consciousness, utilizing existing neuromodulation implants to improve medical treatments. CereGate's technology aims to support patients with neurological disorders or sensory deficits by providing new therapeutic options that enable them to adapt and enhance their conditions independently. The company's approach encompasses a broad range of applications, from sensory substitution to gait improvement.
Emergence Therapeutics
Series A in 2021
Emergence Therapeutics AG is a biopharmaceutical company based in Duisburg, Germany, focused on developing innovative antibody-drug conjugates (ADCs) to address high-need cancers. Established in 2019, the company leverages advanced technologies in antibody design, linker systems, and therapeutic payloads to create targeted treatments. Its lead program specifically targets Nectin-4, a clinically validated marker for various cancers, utilizing a highly specific antibody in combination with optimized linker technology and amanitin as the payload. This approach aims to provide effective therapeutic options for challenging cancer types. Emergence Therapeutics is also exploring opportunities to develop additional first- or best-in-class ADCs to meet unmet medical needs in oncology.
Kiutra
Venture Round in 2021
Kiutra is a Munich-based technology company that designs and manufactures cryogenic cooling and refrigeration solutions for research and industry. It develops turn-key cryostats and magnetic cooling technology that delivers continuous sub-kelvin temperatures without reliance on liquid cooling media, notably avoiding helium-3. The platforms provide compact, cost-efficient cooling and rapid sample exchange, enabling researchers to focus on experiments rather than equipment maintenance. Kiutra’s systems support low-temperature investigations across materials science, quantum technology, high-performance electronics, and detector applications, helping customers push forward basic research and industrial-scale quantum hardware development. By offering cryogen-free cooling and easy-to-use platforms, Kiutra aims to accelerate the development and testing of quantum computing, communications, and sensing technologies.
Nebula Biocides
Seed Round in 2021
Nebula Biocides is a company that specializes in the development of innovative disinfection solutions aimed at effectively combating infection. The company focuses on creating application-oriented products that target persistent bacterial spores and resilient viruses, ensuring comprehensive protection for users in various environments. Nebula Biocides offers a range of smart disinfection devices designed to deliver reliable and efficient disinfection, making them suitable for diverse applications. Through its commitment to effective infection control, Nebula Biocides strives to enhance public health and safety by providing advanced disinfection technologies.
FinMarie
Seed Round in 2021
FinMarie is an innovative financial platform in Germany designed specifically for women, aimed at empowering them to take control of their financial futures. The company focuses on providing education, technology, and personalized solutions to address the unique challenges women face in investing and financial management. By utilizing advanced algorithms, FinMarie helps users set financial goals and assess their risk tolerance, allowing for effective portfolio management and rebalancing. The platform combines digital financial education with tailored guidance to assist women at every stage of their financial journey, ultimately enabling them to build investment and financial security with confidence.
Dimpora
Seed Round in 2021
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.
MetisMotion
Seed Round in 2021
MetisMotion GmbH, founded in 2018 and headquartered in Munich, Germany, specializes in the development of advanced actuators designed for various industrial applications, including robotics, aviation, and automotive sectors. The company focuses on creating lightweight, high force-density actuators that enhance performance through significant reductions in weight and space. MetisMotion's technology integrates the advantages of solid-state actuators with traditional drive systems, facilitating the electrification of hydraulic systems to achieve greater force output and extended displacement capabilities. This innovative approach positions MetisMotion as a key player in driving efficiency and modernization within the actuator market.
Qnami
Series A in 2021
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
PreComb
Seed Round in 2021
PreComb develops advanced technologies to adapt cancer therapies to individual patients, aiming to enhance treatment success rates and improve patient outcomes.
Delft Circuits
Venture Round in 2021
Delft Circuits manufactures specialized hardware for quantum engineers and industries. They offer in-house cleanroom fabrication, cryogenic high-frequency laboratories, and expertise in microwave design, engineering, and superconducting materials to enable customers to achieve scalable, high-performance Input/Output (I/O) solutions.
tech11
Seed Round in 2021
tech11 is a developer of a comprehensive digital platform tailored for the property and casualty insurance sector. The tech11 Insurance Platform facilitates the digital transformation of insurance companies and managing general agents by addressing the complexities associated with legacy systems. This cloud-based solution, which can also be deployed on-premises, supports the complete policy and claims management lifecycle, making it adaptable for both established insurers and new entrants in fast-growing markets. The platform offers various services, including policy management, claim management, document management, and business process management, while accommodating multi-tenant operations, multiple currencies, and different languages. By streamlining these processes, tech11 helps clients navigate the challenges of digitalization in the insurance industry across Europe.
Awake Mobility
Seed Round in 2021
Awake Mobility develops a predictive maintenance platform that supports public and private bus operators with digital transformation. The platform uses IoT and machine learning to monitor city buses in real-time, preventing breakdowns and failures, and providing operators with data on their fleet's health.
Venly
Seed Round in 2021
Venly is a Web3 platform that enables developers to integrate any blockchain into their projects. It focuses on simplifying blockchain technology, facilitating transactions between individuals, ecosystems, and decentralized applications.
HighLine Technology
Pre Seed Round in 2021
HighLine Technology develops and commercializes highly efficient dispensing technology to reduce material usage in the photovoltaics sector and provides dispensing solutions for other industries. Its parallel dispensing technology lowers material consumption in solar cell manufacturing by applying front metal contacts to silicon solar cells and can be integrated into conventional production lines to replace the screen‑printing process for front‑side contacts, enabling resource savings, higher electricity yield, and improved throughput.
MagnoTherm
Seed Round in 2021
MagnoTherm, founded in 2019 and headquartered in Darmstadt, Germany, specializes in innovative magnetic cooling and heating technologies. With a team of over 40 experts in magnetocaloric materials, the company is committed to addressing the climate crisis by revolutionizing the cooling industry, which accounts for approximately 7% of global CO2 emissions. MagnoTherm's technology offers an alternative to traditional gas compression systems, boasting up to 30% greater energy efficiency while being non-explosive, non-flammable, and requiring low maintenance. The company aims to meet the increasing demand for sustainable and cost-effective cooling solutions, providing a viable pathway for policymakers to transition from outdated gas compression methods that have remained unchanged for nearly two centuries.
Crocus Labs
Seed Round in 2021
Crocus Labs is a Berlin-based deep tech company specializing in advanced light engine technology. It develops energy-saving solutions for wellness, horticultural, and specialty lighting applications, aiming to bring its innovations to residential, commercial, and industrial spaces worldwide.
Gilytics
Seed Round in 2020
Gilytics develops fast computing and 3D visualization technology to support planning of transportation and energy infrastructure. It serves industries including transportation networks, pipelines, and planning linear infrastructure, as well as wind and solar energy and large-scale future energy systems, utilities, and power grid operators. The company offers an interactive web application as a software-as-a-service for automated optimal planning and siting of both linear and distributed infrastructure in energy and transport. Its 3D rendering software facilitates planning and visualization of distributed energy infrastructures, providing automated services to identify optimal routes for transmission lines and to improve interaction with authorities and communities through 3D visualization, enabling power management companies to apply the technology for planning and managing distributed energy systems.
Resolve BioSciences
Series A in 2020
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's innovative technology enables researchers to obtain high-resolution spatial views of subcellular gene expression activities. Resolve BioSciences offers a range of services that encompass bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among others. Their expertise extends to various fields, including neuroscience, oncology, infectious diseases, and agrigenomics, facilitating advanced studies in cell atlasing and single-cell analysis.
Synthara
Seed Round in 2020
Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.
Lymphatica Medtech
Series A in 2020
Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.
heartbeat medical
Series A in 2020
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.
Ceregate
Series A in 2020
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company focuses on developing a computer-brain interface (CBI) technology that enhances the programming of neuromodulation systems. This innovative platform allows for the direct transmission of information into human consciousness, utilizing existing neuromodulation implants to improve medical treatments. CereGate's technology aims to support patients with neurological disorders or sensory deficits by providing new therapeutic options that enable them to adapt and enhance their conditions independently. The company's approach encompasses a broad range of applications, from sensory substitution to gait improvement.
WAKU Robotics
Pre Seed Round in 2020
Founded in Berlin, Germany in 2019, WAKU Robotics specializes in digital solutions for selecting, planning, and procuring optimal robot solutions. Its flagship product, WAKU Care, is a software platform for efficient maintenance and after-sales management of autonomous guided vehicles (AGVs) and autonomous mobile robots (AMRs). The company serves international clients, offering services such as repair coordination, process improvement, and spare part management.
Tubulis
Series A in 2020
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
Userlane
Series B in 2020
Userlane automates user onboarding and employee training via interactive guides, helping SaaS providers boost trial conversion, reduce support costs, and increase user engagement. Its platform enables creation of step-by-step guides within minutes without coding or altering underlying software.
Kumovis
Series A in 2020
Kumovis is a medical technology company that specializes in developing a 3D printing system designed for both industrial and medical applications. The company focuses on the processing of high-performance polymers to create patient-customized implants. By integrating clean room technology into its 3D printing solutions, Kumovis enables hospitals to perform medical operations more conveniently and effectively, enhancing the overall quality of care.
Erium
Seed Round in 2020
Erium GmbH is a software development company based in Garching bei München, Germany, founded in 2019. It specializes in creating artificial intelligence (AI) models through its flagship product, HALerium. This innovative software enables professionals from various fields, such as process experts, engineers, and production managers, to independently design and implement their own AI models. Erium's platform facilitates knowledge management by providing an intuitive programming interface, background computation with state preservation, and access to cloud resources. It also allows users to collect, structure, and interconnect information using interactive cards, supporting applications in forensics, prediction, and control.
Noscendo
Series A in 2020
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, focused on the development of bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Utilizing Next Generation Sequencing technology, Noscendo's platform offers a hypothesis-free approach to detect a wide range of infection-causing microbes, including bacteria, fungi, DNA viruses, and parasites, from a single standard blood draw. This innovative method eliminates the need for prior cultivation or specific knowledge about the infection's nature, empowering intensive care clinicians to make accurate distinctions between commensals, contamination, and genuine infections. Through its proprietary algorithms, Noscendo enhances the identification process, ultimately aiming to improve patient outcomes in critical care settings.
Arioso Systems
Venture Round in 2020
Arioso Systems GmbH is a technology company based in Dresden, Germany, that specializes in manufacturing silicon-based micro loudspeakers. The company develops innovative micro-transducer technology featuring rows of 20-micrometer-wide bending strips integrated into silicon chips. Its cutting-edge audio transducer technology utilizes pure silicon Micro-Electromechanical Systems (MEMS), aimed at enhancing sound fidelity in in-ear headsets and hearing aids. By providing a cost-efficient solution for audio applications, Arioso Systems is positioned to revolutionize the market for in-ear audio devices.
Scipio Bioscience
Series A in 2020
Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.
Hprobe
Seed Round in 2020
Hprobe SA is a French company established in 2017, specializing in the design and construction of automated wafer-level magnetic test solutions. Based in Eybens, the company develops a three-dimensional magnetic field generator that enables the characterization and testing of various magnetic devices and sensors, including Magnetic Tunnel Junctions, STT MRAM, and TMR sensors. Hprobe's innovative equipment and software facilitate wafer prober testing automation, catering to the needs of the semiconductor industry, particularly in spintronics-based applications. This technology provides customers with efficient testing solutions critical for mass production and the development of embedded memory technologies in system-on-chip designs.
Ceregate
Venture Round in 2020
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company focuses on developing a computer-brain interface (CBI) technology that enhances the programming of neuromodulation systems. This innovative platform allows for the direct transmission of information into human consciousness, utilizing existing neuromodulation implants to improve medical treatments. CereGate's technology aims to support patients with neurological disorders or sensory deficits by providing new therapeutic options that enable them to adapt and enhance their conditions independently. The company's approach encompasses a broad range of applications, from sensory substitution to gait improvement.
Biograil
Seed Round in 2020
Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is a medical device company focused on developing innovative delivery systems for biologic substances. The company has designed a device that is encapsulated in a standard-sized capsule, utilizing injection molding technology. This device eliminates mechanical moving components and harnesses the body's natural peristaltic forces to facilitate the effective and painless delivery of medications directly into the gastrointestinal wall. By replacing traditional injection methods, Biograil aims to enhance patient comfort and improve the administration of medications.
Lindis Blood Care
Venture Round in 2019
Lindis Blood Care is focused on improving the outcomes of cancer surgeries through the development of an innovative medical device that removes cancer cells from salvaged blood. This technology facilitates the possibility of self-blood administration, allowing cancer patients to receive autologous blood transfusions during their procedures. By enabling the safe use of blood collected during surgery, Lindis Blood Care aims to enhance the recovery process and overall well-being of patients undergoing cancer treatment.
envelio
Series A in 2019
envelio GmbH, founded in 2017 and based in Cologne, Germany, specializes in developing software solutions for the planning and operation of energy networks. The company offers the Intelligent Grid Platform (IGP), a modular software system designed to assist distribution grid operators in digitizing and automating their processes. This platform integrates algorithms based on artificial intelligence and mathematical optimization to facilitate the management of distribution grids, allowing for the seamless incorporation of numerous distributed energy resources and smart meter data. Key features of the IGP include applications for data quality management, automated grid planning, and operational support for congestion management in response to potential grid bottlenecks. By enabling grid operators to optimize their operations, envelio plays a crucial role in advancing the energy transition and enhancing grid sustainability and flexibility.
Verovaccines
Seed Round in 2019
VEROVACCiNES GmbH is a biopharmaceutical company based in Halle, Germany, founded in 2017 as a spin-off from the Martin Luther University Halle-Wittenberg. The company specializes in developing innovative vaccine solutions to protect animals from infectious diseases, utilizing a unique yeast-based technology to create subunit marker vaccines. This approach has been validated through proof-of-concept studies demonstrating protection across various animal species against several viral diseases. VEROVACCiNES has acquired intellectual property, branding, and expertise from a previous project funded by the BMBF GO-Bio program and is eligible for additional funding. The company actively collaborates with veterinary pharmaceutical firms, universities, and research institutions to enhance its vaccine development efforts.
Laclarée
Seed Round in 2019
Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.
Qnami
Seed Round in 2019
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
Spherity
Seed Round in 2019
Spherity GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing decentralized applications that enhance interoperable supply chains, machine-to-machine communication, and ensure data authenticity and privacy. The company integrates IoT, blockchain technology, and advanced cryptography to create secure data audit trails, facilitate asset management, and support token streaming. Spherity's offerings include a customizable cloud identity wallet that provides secure and tamper-proof business transactions, enabling organizations to manage digital identities and credentials effectively. This technology allows for robust access control and lifecycle management, improving authenticity and data exchange across complex business processes and value chains.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.